| Literature DB >> 19679215 |
Alvaro Whittembury1, Gladys Ramirez, Herminio Hernández, Alba Maria Ropero, Steve Waterman, María Ticona, Margo Brinton, Jorge Uchuya, Mark Gershman, Washington Toledo, Erin Staples, Clarense Campos, Mario Martínez, Gwong-Jen J Chang, Cesar Cabezas, Robert Lanciotti, Sherif Zaki, Joel M Montgomery, Thomas Monath, Edward Hayes.
Abstract
Five suspected cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) clustered in space and time following a vaccination campaign in Ica, Peru in 2007. All five people received the same lot of 17DD live attenuated yellow fever vaccine before their illness; four of the five died of confirmed YEL-AVD. The surviving case was classified as probable YEL-AVD. Intensive investigation yielded no abnormalities of the implicated vaccine lot and no common risk factors. This is the first described space-time cluster of yellow fever viscerotropic disease involving more than two cases. Mass yellow fever vaccination should be avoided in areas that present extremely low risk of yellow fever.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19679215 DOI: 10.1016/j.vaccine.2009.07.082
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641